InvestorsObserver
×
News Home

Denali Therapeutics Inc (DNLI) Stock Climbs 10.58% This Week; Should You Buy?

Tuesday, October 27, 2020 04:14 PM | InvestorsObserver Analysts

Mentioned in this article

Denali Therapeutics Inc (DNLI) Stock Climbs 10.58% This Week; Should You Buy?

Denali Therapeutics Inc (DNLI) stock is up 192.42% over the last 12 months, and the average rating from Wall Street analysts is a Buy. InvestorsObserver’s proprietary ranking system, gives DNLI stock a score of 66 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 100. DNLI's rank also includes a long-term technical score of 96. The fundamental score for DNLI is 3. In addition to the average rating from Wall Street analysts, DNLI stock has a mean target price of 37.5. This means analysts expect the stock to fall 18.27% over the next 12 months.

Overall Score - 66
DNLI has an Overall Score of 66. Find out what this means to you and get the rest of the rankings on DNLI!

What's Happening with DNLI Stock Today

Denali Therapeutics Inc (DNLI) stock has gained 9.03% while the S&P 500 has fallen -0.3% as of 4:00 PM on Tuesday, Oct 27. DNLI is up $3.80 from the previous closing price of $42.08 on volume of 478,607 shares. Over the past year the S&P 500 has gained 11.56% while DNLI is up 192.42%. DNLI lost -$2.15 per share in the over the last 12 months.

Click Here to get the full Stock Score Report on Denali Therapeutics Inc (DNLI) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App